Projects per year
Fingerprint
Dive into the research topics where Alex Adjei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 20 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
-
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
Adjei, A., Adjei, A., Kinney, L., Kinney, L., Kinney, L. & Kinney, L.
Project: Research project
-
-
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
Project: Research project
-
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
Haluska, P. R. J., Ramanathan, R., Adjei, A., Ramanathan, R. K., Erlichman, C., Adjei, A., Erlichman, C., Haluska, P. R. J. & Kinney, L.
4/7/14 → 3/31/19
Project: Research project
Research Output
-
A Call for Rapid Submission of Data for Aggregate Review: Can Daily Radiotherapy Imaging Be Used as a Potential Screen for Coronavirus Disease 2019?
Warren, G. W. & Adjei, A. A., Jun 2020, In: Journal of Thoracic Oncology. 15, 6, p. 876-877 2 p.Research output: Contribution to journal › Editorial › peer-review
-
A Call to Arms: Reducing Disparities in Lung Cancer Care Worldwide
Adjei, A. A., Nov 2020, In: Journal of Thoracic Oncology. 15, 11, p. 1700-1702 3 p.Research output: Contribution to journal › Editorial › peer-review
-
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)
Parikh, K., Mandrekar, S. J., Allen-Ziegler, K., Esplin, B., Tan, A. D., Marchello, B., Adjei, A. A. & Molina, J. R., Jun 1 2020, In: Oncologist. 25, 6, p. 523-531 9 p.Research output: Contribution to journal › Article › peer-review
-
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
Zhu, M., Molina, J. R., Dy, G. K., Croghan, G. A., Qi, Y., Glockner, J., Hanson, L. J., Roos, M. M., Tan, A. D. & Adjei, A. A., Dec 1 2020, In: Investigational New Drugs. 38, 6, p. 1755-1762 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
Schenk, E. L., Mandrekar, S. J., Dy, G. K., Aubry, M. C., Tan, A. D., Dakhil, S. R., Sachs, B. A., Nieva, J. J., Bertino, E., Lee Hann, C., Schild, S. E., Wadsworth, T. W., Adjei, A. A. & Molina, J. R., Jan 2020, In: Journal of Thoracic Oncology. 15, 1, p. 110-119 10 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations